File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Safety, Tolerability, and Pharmacokinetics of ARC-520 Injection, an RNA Interference-Based Therapeutic for the Treatment of Chronic Hepatitis B Virus Infection, in Healthy Volunteers

TitleSafety, Tolerability, and Pharmacokinetics of ARC-520 Injection, an RNA Interference-Based Therapeutic for the Treatment of Chronic Hepatitis B Virus Infection, in Healthy Volunteers
Authors
Schluep, TLickliter, JHamilton, JLewis, DLLai, CLLau, JYNLocarnini, SAGish, RGGiven, BD
Keywordshepatitis B
pharmacokinetics
pharmacology
phase 1
RNA interference
RNAi
safety
tolerability
treatment
viral hepatitis
volunteers
Issue Date2017
PublisherWiley-Blackwell Publishing Ltd. The Journal's web site is located at http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)10.1002(ISSN)2160-7648
Citation
Clinical Pharmacology in Drug Development, 2017, v. 6 n. 4, p. 350-362 How to Cite?
DOI: http://dx.doi.org/10.1002/cpdd.318
Persistent Identifierhttp://hdl.handle.net/10722/247514
ISSN
2160-763X
2020 SCImago Journal Rankings: 0.711
ISI Accession Number ID
WOS:000405637900004

 

DC FieldValueLanguage
dc.contributor.authorSchluep, T-
dc.contributor.authorLickliter, J-
dc.contributor.authorHamilton, J-
dc.contributor.authorLewis, DL-
dc.contributor.authorLai, CL-
dc.contributor.authorLau, JYN-
dc.contributor.authorLocarnini, SA-
dc.contributor.authorGish, RG-
dc.contributor.authorGiven, BD-
dc.date.accessioned2017-10-18T08:28:28Z-
dc.date.available2017-10-18T08:28:28Z-
dc.date.issued2017-
dc.identifier.citationClinical Pharmacology in Drug Development, 2017, v. 6 n. 4, p. 350-362-
dc.identifier.issn2160-763X-
dc.identifier.urihttp://hdl.handle.net/10722/247514-
dc.languageeng-
dc.publisherWiley-Blackwell Publishing Ltd. The Journal's web site is located at http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)10.1002(ISSN)2160-7648-
dc.relation.ispartofClinical Pharmacology in Drug Development-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjecthepatitis B-
dc.subjectpharmacokinetics-
dc.subjectpharmacology-
dc.subjectphase 1-
dc.subjectRNA interference-
dc.subjectRNAi-
dc.subjectsafety-
dc.subjecttolerability-
dc.subjecttreatment-
dc.subjectviral hepatitis-
dc.subjectvolunteers-
dc.titleSafety, Tolerability, and Pharmacokinetics of ARC-520 Injection, an RNA Interference-Based Therapeutic for the Treatment of Chronic Hepatitis B Virus Infection, in Healthy Volunteers-
dc.typeArticle-
dc.identifier.emailLai, CL: hrmelcl@hkucc.hku.hk-
dc.identifier.authorityLai, CL=rp00314-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.1002/cpdd.318-
dc.identifier.scopuseid_2-s2.0-85023208957-
dc.identifier.hkuros280987-
dc.identifier.volume6-
dc.identifier.issue4-
dc.identifier.spage350-
dc.identifier.epage362-
dc.identifier.isiWOS:000405637900004-
dc.publisher.placeUnited Kingdom-
dc.identifier.issnl2160-763X-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats